Applonia Rose, Managing Editor at Sage Publishing, shared a post on LinkedIn:

“March is Colorectal Cancer Awareness Month – Advancing research for better outcomes!

Colorectal cancer (CRC) is the third most common cancer worldwide, responsible for 10% of all cases and the second leading cause of cancer-related deaths. While CRC is often diagnosed at advanced stages, early detection, innovative treatments and a deeper understanding of its molecular landscape are transforming patient care.

TCRT is proud to showcase our impactful review articles on CRC, including:

Recent Advancements, Limitations, and Future Perspectives of the use of Personalized Medicine in Treatment of Colon Cancer

Molecular Biomarkers and Signaling Pathways of Cancer Stem Cells in Colorectal Cancer

Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology

Research Progress of Intestinal Microecology in the Pathogenesis of Colorectal Adenoma and Carcinogenesis

Shedding Light on the Prognostic and Predictive Value of Circulating Tumor DNA for Management of Patients with Early-Stage Colon Cancer

Early screening and prevention can save lives! By adopting a healthy lifestyle and utilizing cutting-edge diagnostic tools, we can reduce the global burden of CRC.

Explore the latest colorectal cancer research in TCRT and join us in the fight against CRC! Interested in submitting your work? Learn more here.”

Applonia Rose: TCRT’s impactful review articles on colorectal cancer